BU-NOT-SET

CONTACT US
Dosage form development trends and technologies
  • Drug product
Eyes
Insight
Vaccine Development and Manufacturing
  • Drug product
  • Manufacturing
Eyes
Insight
Identifying impurities using advanced analytics
  • Analytical chemistry
Eyes
Insight
Recipharm on the impact of COVID-19 on API supply
  • Industry trends
Eyes
Insight
The role of excipient selection in the development of orally disintegrating tablets
  • Drug product
Eyes
Insight
Solving analytical method challenges to advance animal antibiotic
  • Analytical chemistry
Hand vial stand
Case study
The outlook for a year of change
  • Industry trends
Eyes
Insight
Can oral solid dose keep its place as the leading dosage form?
  • Drug product
Eyes
Insight
Relocating API supply to avoid over-reliance
  • Drug substance
Eyes
Insight
Insight
  • Manufacturing
Why outsourcing is key to bringing flexibility and capacity to the manufacture of oral solid dosage forms
Insight
  • Industry trends
Can bigger be better?
Insight
  • Industry trends
What does 2017 have in store for the pharma industry?
Insight
  • Industry trends
Reflecting on 2017 | the factors shaping our industry
Insight
  • Manufacturing
Protecting against counterfeiting with serialisation
Insight
  • Industry trends
Manufacturing Chemist CDMO roundtable – part two
Insight
  • Industry trends
Manufacturing Chemist CDMO roundtable – part one
Insight
  • Industry trends
  • Manufacturing
Increased drive to outsource manufacturing in life science
Insight
  • Manufacturing
Serialisation: the final countdown